Kyverna Therapeutics (Series A)

Funding Details
Awarder
Inbox
Date Award
January 14, 2020
Vertical
Cell Therapy
Funding URL
View Funding Page
Funding Amount:
$25,000,000

Company Info
Founders
Dominic Borie
Company Description
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Market
Autoimmune Diseases
Location
Berkeley, California, USA
Coinvestors
Gilead Sciences, Vida Ventures, Westlake Village BioPartners

Links